The homogeneity of cardiovascular clinical trial populations limits the generalizability of results and compounds health inequities faced by women, older adults and people of colour. This Comment highlights the importance of diversity in clinical trial populations and describes multifaceted interventions that might help to close the diversity gap in trial enrolment.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Diversity in randomized clinical trials for peripheral artery disease: a systematic review
International Journal for Equity in Health Open Access 13 February 2024
-
Leveraging Digital Health to Improve the Cardiovascular Health of Women
Current Cardiovascular Risk Reports Open Access 30 September 2023
-
Clinical Trial Technologies for Improving Equity and Inclusion in Cardiovascular Clinical Research
Cardiology and Therapy Open Access 12 April 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Khan, S. U. & Michos, E. D. Women in stroke trials — a tale of perpetual inequity in cardiovascular research. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2021.0624 (2021).
Khan, S. U. et al. Participation of women and older participants in randomized clinical trials of lipid-lowering therapies: a systematic review. JAMA Netw. Open 3, e205202 (2020).
Khan, M. S. et al. Ten-year trends in enrollment of women and minorities in pivotal trials supporting recent US Food and Drug Administration approval of novel cardiometabolic drugs. J. Am. Heart Assoc. 9, e015594 (2020).
Tahhan, A. S. et al. Enrollment of older patients, women, and racial/ethnic minority groups in contemporary acute coronary syndrome clinical trials: a systematic review. JAMA Cardiol. 5, 714–722 (2020).
Tahhan, A. S. et al. Enrollment of older patients, women, and racial and ethnic minorities in contemporary heart failure clinical trials: a systematic review. JAMA Cardiol. 3, 1011–1019 (2018).
Whitelaw, S. et al. Trial characteristics associated with under-enrolment of females in randomized controlled trials of heart failure with reduced ejection fraction: a systematic review. Eur. J. Heart Fail. 23, 15–24 (2021).
Van Spall, H. G. C. Exclusion of pregnant and lactating women from COVID-19 vaccine trials: a missed opportunity. Eur. Heart J. https://doi.org/10.1093/eurheartj/ehab103 (2021).
Chen, S. & Li, J. Participation of Black US residents in clinical trials of 24 cardiovascular drugs granted FDA approval, 2006–2020. JAMA Netw. Open 4, e212640 (2021).
Cherubini, A. et al. The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. Arch. Intern. Med. 171, 550–556 (2011).
Van Spall, H. G. C., Toren, A., Kiss, A. & Fowler, R. A. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA 297, 1233–1240 (2007).
Acknowledgements
E.D.M. is supported by the Amato Fund in Women’s Cardiovascular Health at Johns Hopkins University School of Medicine. H.G.C.V. is supported by funding from the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Canada.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Michos, E.D., Van Spall, H.G.C. Increasing representation and diversity in cardiovascular clinical trial populations. Nat Rev Cardiol 18, 537–538 (2021). https://doi.org/10.1038/s41569-021-00583-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41569-021-00583-8
This article is cited by
-
Diversity in randomized clinical trials for peripheral artery disease: a systematic review
International Journal for Equity in Health (2024)
-
Cardiovascular events risk in patients with systemic autoimmune diseases: a prognostic systematic review and meta-analysis
Clinical Research in Cardiology (2024)
-
Pregnant and lactating women should be included in clinical trials for cardiovascular disease
Nature Medicine (2023)
-
Strategies for Improving Enrollment of Diverse Populations with a Focus on Lipid-Lowering Clinical Trials
Current Cardiology Reports (2023)
-
Clinical Trial Technologies for Improving Equity and Inclusion in Cardiovascular Clinical Research
Cardiology and Therapy (2023)